Perforated tissue matrix
US-2024408277-A1 · Dec 12, 2024 · US
US10034967B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10034967-B2 |
| Application number | US-201615219133-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 25, 2016 |
| Priority date | Sep 26, 2002 |
| Publication date | Jul 31, 2018 |
| Grant date | Jul 31, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Implantable materials having defined patterns of affinity regions for binding endothelial cells and providing for directed endothelial cell migration across the surface of the material. The affinity regions include photochemically altered regions of a material surface and physical members patterned on the material surface that exhibit a greater affinity for endothelial cell binding and migration than the remaining regions of the material surface.
Opening claim text (preview).
What is claimed is: 1. An implantable biomaterial having at least one surface thereof that comprises the biomaterial and a defined pattern of a plurality of functional features having a height above the at least one surface greater than 0μ, each of the plurality of functional features having a greater endothelial cell binding affinity greater than an endothelial cell binding affinity of the biomaterial. 2. The implantable biomaterial according to claim 1 , wherein each of the plurality of functional features further comprises a titanium oxide layer. 3. The implantable biomaterial according to claim 1 , wherein the biomaterial is made of a material that comprises a nickel-titanium alloy. 4. The implantable biomaterial according to claim 1 , wherein each of the plurality of functional features is made of a material that comprises carbon. 5. The implantable biomaterial according to claim 1 , wherein the functional features have a height between greater than 0μ to about 3.0μ. 6. The implantable biomaterial according to claim 1 , wherein each of the functional features comprises a focal adhesion point for affinity binding of endothelial cells. 7. The implantable biomaterial according to claim 1 , wherein each of the functional features has a width between about 10 μm to about 75 μm. 8. The implantable biomaterial according to claim 1 , further comprising a gap distance between adjacent functional features between about 10 μm to about 75 μm.
Prostheses implantable into the body · CPC title
Coating made of titanium oxide or hydroxides · CPC title
Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (dental prostheses A61C13/00; artificial kidneys A61M1/14; artificial hearts A61M60/00) · CPC title
Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence) · CPC title
for preferentially controlling or promoting the growth of specific types of cells or tissues · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.